RU2008140022A - SUBSTITUTED IMIDAZO [2,1-b] THIAZOLE AND THEIR APPLICATION FOR PREPARATION OF MEDICINES - Google Patents
SUBSTITUTED IMIDAZO [2,1-b] THIAZOLE AND THEIR APPLICATION FOR PREPARATION OF MEDICINES Download PDFInfo
- Publication number
- RU2008140022A RU2008140022A RU2008140022/04A RU2008140022A RU2008140022A RU 2008140022 A RU2008140022 A RU 2008140022A RU 2008140022/04 A RU2008140022/04 A RU 2008140022/04A RU 2008140022 A RU2008140022 A RU 2008140022A RU 2008140022 A RU2008140022 A RU 2008140022A
- Authority
- RU
- Russia
- Prior art keywords
- butyl
- group
- unsubstituted
- tert
- phenyl
- Prior art date
Links
- 0 C*c1ccc(S)[s]1 Chemical compound C*c1ccc(S)[s]1 0.000 description 6
- QFYWDJHDOCZKRF-UHFFFAOYSA-N CCCCCc1ncc[s]1 Chemical compound CCCCCc1ncc[s]1 QFYWDJHDOCZKRF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
1. Замещенные имидазо[2,1-b]тиазолы общей формулы I ! , ! в которой R1 и R2 независимо друг от друга обозначают водород, галоген, -NO2, -CN, -NH2, -NHR5, -NR6R7, -NH-C(=O)-R8, -C(=O)-R9, -C(=O)-NH2, -C(=O)-NHR10, -C(=O)-NR11R12, -C(=O)-OR13, -(CH2)m-C(=O)-OR14, где m обозначает 1, 2, 3, 4 или 5, -O-C(=O)-R15, -(CH2)n-O-C(=O)-R16, где n обозначает 1, 2, 3, 4 или 5, -OR17, -(CH2)o-О-R18, где o обозначает 1, 2, 3, 4 или 5, -SR19, -(CH2)p-S(=O)t-R20, где p обозначает 1, 2, 3, 4 или 5, a t обозначает 0, 1 или 2, -NH-S(=O)2-NR27R28, -S(=O)2-NR29R30, -SF5, -(CH2)u-O-S(=O)2-R31, где u обозначает 1, 2, 3, 4 или 5, -(CH2)v-O-S(=O)2-O-R32, где v обозначает 1, 2, 3, 4 или 5, -(CH2)w-O-P(=O)(OR33)(OR34), где w обозначает 1, 2, 3, 4 или 5, линейный либо разветвленный, насыщенный либо ненасыщенный, незамещенный либо по меньшей мере однозамещенный алифатический остаток, насыщенный либо ненасыщенный, незамещенный либо по меньшей мере однозамещенный, необязательно содержащий гетероатом в качестве кольцевого члена циклоалифатический остаток, который может быть присоединен через линейную либо разветвленную, незамещенную либо по меньшей мере однозамещенную алкиленовую группу и/или может быть сконденсирован с незамещенной либо по меньшей мере однозамещенной моно- или полициклической системой, или незамещенный либо по меньшей мере однозамещенный арильный либо гетероарильный остаток, который может быть присоединен через линейную либо разветвленную, незамещенную либо по меньшей мере однозамещенную алкиленовую группу и/или может быть сконденсирован с незамещенной либо по меньшей мере однозамещенной моно- или полициклической системой, ! R3 и R4 независимо друг от друга обозначают водород, -C(=O)-R21, -(CH2)q-C(=O)-R22, где q обозначает 1, 2, 3, 4 или 5, -C(=O)-O-R23, -(CH2)r-C(=O)-O-R24, где r обозначает 1, 2, 3, 4 или 5, -C(=O)-NHR25, -(CH2)s-C(=O)-NHR26, где s обозначает 1, 2, 3, 4 или 5, линейны� 1. Substituted imidazo [2,1-b] thiazoles of general formula I! ! in which R1 and R2 are independently hydrogen, halogen, -NO2, -CN, -NH2, -NHR5, -NR6R7, -NH-C (= O) -R8, -C (= O) -R9, - C (= O) -NH2, -C (= O) -NHR10, -C (= O) -NR11R12, -C (= O) -OR13, - (CH2) mC (= O) -OR14, where m is 1, 2, 3, 4 or 5, -OC (= O) -R15, - (CH2) nOC (= O) -R16, where n is 1, 2, 3, 4 or 5, -OR17, - (CH2 ) o-O-R18, where o is 1, 2, 3, 4 or 5, -SR19, - (CH2) pS (= O) t-R20, where p is 1, 2, 3, 4 or 5, at denotes 0, 1 or 2, -NH-S (= O) 2-NR27R28, -S (= O) 2-NR29R30, -SF5, - (CH2) uOS (= O) 2-R31, where u is 1, 2, 3, 4 or 5, - (CH2) vOS (= O) 2-O-R32, where v is 1, 2, 3, 4 or 5, - (CH2) wOP (= O) (OR33) (OR34) ), where w denotes 1, 2, 3, 4 or 5, linear or branched, saturated or unsaturated, unsubstituted at least a monosubstituted aliphatic residue, saturated or unsaturated, unsubstituted or at least monosubstituted, optionally containing a heteroatom as a ring member, a cycloaliphatic residue that may be attached via a linear or branched, unsubstituted or at least monosubstituted alkylene group and / or may be condensed with an unsubstituted or at least monosubstituted mono- or polycyclic system, or unsubstituted or at least monosubstituted ar an alkyl or heteroaryl residue which may be attached via a linear or branched, unsubstituted or at least monosubstituted alkylene group and / or may be condensed with an unsubstituted or at least monosubstituted mono- or polycyclic system! R3 and R4 are independently hydrogen, -C (= O) -R21, - (CH2) qC (= O) -R22, where q is 1, 2, 3, 4 or 5, -C (= O) -O-R23, - (CH2) rC (= O) -O-R24, where r is 1, 2, 3, 4 or 5, -C (= O) -NHR25, - (CH2) sC (= O) -NHR26, where s is 1, 2, 3, 4 or 5, linear
Claims (34)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102006011574.0 | 2006-03-10 | ||
DE102006011574A DE102006011574A1 (en) | 2006-03-10 | 2006-03-10 | Substituted imidazo [2,1-b] thiazole compounds and their use for the preparation of medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2008140022A true RU2008140022A (en) | 2010-05-10 |
RU2450010C2 RU2450010C2 (en) | 2012-05-10 |
Family
ID=38370833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008140022/04A RU2450010C2 (en) | 2006-03-10 | 2007-03-09 | SUBSTITUTED IMIDAZO{2,1-b}THIAZOLES AND APPLICATION THEREOF FOR MAKING DRUG PREPARATIONS |
Country Status (16)
Country | Link |
---|---|
US (1) | US7893069B2 (en) |
EP (1) | EP1996596B1 (en) |
JP (1) | JP2009529508A (en) |
KR (1) | KR20080108534A (en) |
CN (1) | CN101421281A (en) |
AU (1) | AU2007224678B2 (en) |
BR (1) | BRPI0708740A2 (en) |
CA (1) | CA2643410A1 (en) |
DE (1) | DE102006011574A1 (en) |
ES (1) | ES2549112T3 (en) |
MX (1) | MX2008011576A (en) |
NO (1) | NO20084177L (en) |
NZ (1) | NZ570710A (en) |
RU (1) | RU2450010C2 (en) |
WO (1) | WO2007104485A2 (en) |
ZA (1) | ZA200807321B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1884515A1 (en) * | 2006-07-31 | 2008-02-06 | Laboratorios del Dr. Esteve S.A. | Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
US7868001B2 (en) * | 2007-11-02 | 2011-01-11 | Hutchison Medipharma Enterprises Limited | Cytokine inhibitors |
GB0800414D0 (en) * | 2008-01-10 | 2008-02-20 | Glaxo Group Ltd | Novel use |
CA2782947A1 (en) | 2009-12-18 | 2011-06-23 | Janssen Pharmaceutica Nv | Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
EP2513117B1 (en) | 2009-12-18 | 2013-08-28 | Janssen Pharmaceutica, N.V. | Bicyclic thiazoles as allosteric modulators of mglur5 receptors |
GB201321731D0 (en) | 2013-12-09 | 2014-01-22 | Ucb Pharma Sa | Therapeutic agents |
KR101719321B1 (en) * | 2016-03-31 | 2017-03-23 | 충남대학교산학협력단 | Composition for treating obesity or depressive disorder comprising 3-(4-chlorophenyl)benzo[4,5]imidazo[2,1-b]thiazole-6-carboxylic acid |
WO2022042613A1 (en) * | 2020-08-27 | 2022-03-03 | 上海和誉生物医药科技有限公司 | 1h-pyrazol-4-amide derivative, preparation method therefor, and use thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE755204A (en) * | 1969-10-01 | 1971-02-01 | Chinoin Gyogyszer Es Vegyeszet | |
SU910636A1 (en) * | 1980-07-11 | 1982-03-07 | Институт Органической Химии Ан Усср | 2,3,5,6-tetrahydro-6-phenyl-7-phenacyclimidazo-[2,1-b thiazolium! bromide exhibiting immuno controlling activity |
HUP0203140A3 (en) * | 1999-10-08 | 2004-06-28 | Gruenenthal Gmbh | Bicyclic imidazo-5-yl-amine derivatives, process for their preparation and pharmaceutical compositions containing them |
DE19948434A1 (en) * | 1999-10-08 | 2001-06-07 | Gruenenthal Gmbh | Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amines |
CN1257894C (en) * | 2000-12-04 | 2006-05-31 | 弗·哈夫曼-拉罗切有限公司 | Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists |
EP1539749A4 (en) * | 2002-09-13 | 2007-06-13 | Merck & Co Inc | Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
TWI292318B (en) * | 2003-03-10 | 2008-01-11 | Hoffmann La Roche | Imidazol-4-yl-ethynyl-pyridine derivatives |
UA80888C2 (en) * | 2003-06-05 | 2007-11-12 | Hoffmann La Roche | Imidazole derivatives as glutmate receptor antagonists |
MXPA05013233A (en) * | 2003-06-12 | 2006-03-09 | Hoffmann La Roche | Heteroaryl-substituted imdazole derivatives as glutamate receptor antagonists. |
EP1756086B1 (en) * | 2004-06-01 | 2008-06-04 | F.Hoffmann-La Roche Ag | Pyridin-4-yl-ethynyl-imidazoles and pyrazoles as mglu5 receptor antagonists |
DE102004044884A1 (en) * | 2004-09-14 | 2006-05-24 | Grünenthal GmbH | Substituted bicyclic imidazo-3-yl-amine compounds |
-
2006
- 2006-03-10 DE DE102006011574A patent/DE102006011574A1/en not_active Withdrawn
-
2007
- 2007-03-09 EP EP07711873.5A patent/EP1996596B1/en active Active
- 2007-03-09 ES ES07711873.5T patent/ES2549112T3/en active Active
- 2007-03-09 AU AU2007224678A patent/AU2007224678B2/en not_active Ceased
- 2007-03-09 BR BRPI0708740-3A patent/BRPI0708740A2/en not_active Application Discontinuation
- 2007-03-09 CN CNA2007800135187A patent/CN101421281A/en active Pending
- 2007-03-09 MX MX2008011576A patent/MX2008011576A/en active IP Right Grant
- 2007-03-09 NZ NZ570710A patent/NZ570710A/en not_active IP Right Cessation
- 2007-03-09 KR KR1020087024772A patent/KR20080108534A/en not_active Application Discontinuation
- 2007-03-09 CA CA002643410A patent/CA2643410A1/en not_active Abandoned
- 2007-03-09 RU RU2008140022/04A patent/RU2450010C2/en not_active IP Right Cessation
- 2007-03-09 WO PCT/EP2007/002067 patent/WO2007104485A2/en active Application Filing
- 2007-03-09 JP JP2008557671A patent/JP2009529508A/en active Pending
-
2008
- 2008-08-25 ZA ZA200807321A patent/ZA200807321B/en unknown
- 2008-09-09 US US12/207,307 patent/US7893069B2/en not_active Expired - Fee Related
- 2008-10-06 NO NO20084177A patent/NO20084177L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BRPI0708740A2 (en) | 2011-06-14 |
DE102006011574A1 (en) | 2007-10-31 |
RU2450010C2 (en) | 2012-05-10 |
WO2007104485A3 (en) | 2007-11-08 |
NO20084177L (en) | 2008-11-12 |
ZA200807321B (en) | 2009-07-29 |
JP2009529508A (en) | 2009-08-20 |
AU2007224678B2 (en) | 2012-08-16 |
NZ570710A (en) | 2010-05-28 |
EP1996596B1 (en) | 2015-07-08 |
US7893069B2 (en) | 2011-02-22 |
CN101421281A (en) | 2009-04-29 |
WO2007104485A2 (en) | 2007-09-20 |
ES2549112T3 (en) | 2015-10-23 |
CA2643410A1 (en) | 2007-09-20 |
KR20080108534A (en) | 2008-12-15 |
EP1996596A2 (en) | 2008-12-03 |
AU2007224678A1 (en) | 2007-09-20 |
US20090005399A1 (en) | 2009-01-01 |
MX2008011576A (en) | 2008-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2008140022A (en) | SUBSTITUTED IMIDAZO [2,1-b] THIAZOLE AND THEIR APPLICATION FOR PREPARATION OF MEDICINES | |
JP4193949B2 (en) | Bicyclic [3.1.0] heteroarylamides as type I glycine transport inhibitors | |
CN102627609B (en) | Heterocyclic aspartyl protease inhibitors | |
US7678815B2 (en) | Thiazole-4-carboxyamide derivatives | |
RU2435770C2 (en) | SUBSTITUTED BICYCLIC IMDAZO-3-YLAMINES SUITABLE FOR REGULARING mGluR5-RECEPTOR | |
JP5085659B2 (en) | Indazole derivatives useful as L-CPT1 inhibitors | |
JP2007534719A5 (en) | ||
JP2007517895A (en) | 2- (Amino-substituted) -4-arylpyrimidines and related compounds useful for treating inflammatory diseases | |
JP2009263377A (en) | Potassium channel modulator | |
EP2146981A1 (en) | Pharmaceutical compounds | |
WO2009086044A1 (en) | Prolyl hydroxylase inhibitors | |
US9029357B2 (en) | Benzazole derivatives as histamine H4 receptor ligands | |
CA2591033A1 (en) | Heterocyclic aspartyl protease inhibitors | |
EP2334643A1 (en) | Phenethylamide derivatives and their heterocyclic analogues | |
WO2008024634A1 (en) | Pyrimdine compounds useful as kinase inhibitors | |
WO2016009297A1 (en) | Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators | |
JP2005514454A6 (en) | Potassium channel modulator | |
JP2002544278A (en) | Imidazo and pyrrolo [1,2-a] pyrimid-4-ones as gonadotropin releasing hormone receptor antagonists | |
JP2010529001A (en) | Piperidine amide derivatives | |
WO1998028299A2 (en) | Imidazopyridazines | |
WO2004024060A2 (en) | Metalloproteinase inhibitors and intermediates for preparation thereof | |
CN111868035A (en) | Substituted pyrazole FFA4/GPR120 receptor agonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20130310 |